ArticleTherapeutic advances in medical oncology2020

Safety and efficacy of extended dosing intervals of denosumab in patients with solid cancers and bone metastases: a retrospective study.

Aseala I Abousaud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.